Stay updated with breaking news from Pharma Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PHILADELPHIA, PA / ACCESSWIRE / May 3, 2023 / Envision Pharma Group (Envision) has appointed Mike Glover to Senior Vice President, Payer and HTA Solutions. Mike will be responsible for leading and developing
Xeltis presents excellent six-month first-in-human data from aXess hemodialysis vascular graft trial at Vascular Access Society Congress aXess graft demonstrated excellent patency
BELOIT - NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic and medical imaging applications,... | April 19, 2023
The following stocks are the best and worst performers on Italy Growth Tuesday afternoon in Piazza Affari. --------- WINNERS ---------- Shedir Pharma Group takes the top spot with a 6.0 percent rise... | April 18, 2023
Pemigatinib generated efficacy and tolerability in previously treated patients with advanced/metastatic or unresectable solid tumors harboring activating FGFR mutations or fusions/rearrangements, including cholangiocarcinoma, central nervous system tumors, gynecologic tumors, and pancreatic cancer.